Why does acetylcholine exacerbate myasthenia caused by anti-MuSK antibodies?

Journal of Physiology

Volumn 591, Issue 10, 2013, Pages 2377-2377

  Engel, Andrew G ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR ANTIBODY; ENZYME ANTIBODY; IMMUNOGLOBULIN G; MEMBRANE PROTEIN; MUSK ANTIBODY; NEOSTIGMINE; PROTEIN MUSK; PYRIDOSTIGMINE; UNCLASSIFIED DRUG;

ARTICLE; DISEASE EXACERBATION; DRUG EFFICACY; DRUG MEGADOSE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOPRECIPITATION; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; NEUROMUSCULAR SYNAPSE; NEUROMUSCULAR TRANSMISSION; NONHUMAN; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; TISSUE SPECIFICITY;

ACETYLCHOLINE; ANIMALS; ANTIBODIES; HUMANS; MYASTHENIA GRAVIS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC;

EID: 84877838462     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2013.254599     Document Type: Article

References (7)

1. Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A & Vincent A (2001). Nat Med 7, 365-368.
2. Kawakami Y, Ito M, Hirayam M, Sahashi K, Ohkawara B, Masuda A, Nishida H, Mabuchi N & Engel AG (2011). Neurology 77, 1819-1826.
3. Misgeld T, Kummer TT, Lichtman JW & Sanes Jr. (2005). Proc Natl Acad Sci U S A 102, 11088-11093.
4. Morsch M, Reddel SW, Ghazanfari N, Toyka KV, & Phillips WD (2013). J Physiol 591, 2747-2762.
5. Punga AR, Lin S, Oliveri F, Meinen S & Ruegg MA (2011). Exp Neurol 230, 207-217.
6. Wu H, Xiong WC & Mei L (2010). Development 137, 1017-1033.
7. Zhu H, Bhattacharyya BJ, Lin H & Gomez CM (2011). J Neurosci 31, 15269-15283.